← Open Payments lookup

JENNIFER SCHAEFFER: Open Payments

NPI 1821292277 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,855 in 78 payments from 14 companies in 2025. Trend: 2023 $1,014 · 2024 $1,535 · 2025 $1,855

Food & beverage: $1,801Education: $54
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.12$345
Janssen Biotech, Inc.16$319
ABBVIE INC.15$246
Madrigal Pharmaceuticals6$244
PFIZER INC.5$132
Gilead Sciences, Inc.5$123
Lilly USA, LLC4$87
GENZYME CORPORATION2$69
Celltrion USA Inc.4$66
Phathom Pharmaceuticals, Inc.2$58

Products named: ENTYVIO, TREMFYA, REZDIFFRA, SKYRIZI, OMVOH, XELJANZ, DUPIXENT, VEGZELMA.

Industry payments across AZ — which companies pay providers there.